Barclays’s Innoviva INVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10M | Sell |
430,879
-157,650
| -27% | -$3.4M | ﹤0.01% | 1450 |
|
|
2025
Q4 | $11.8M | Buy |
588,529
+253,752
| +76% | +$4.96M | ﹤0.01% | 1568 |
|
|
2025
Q3 | $6.11M | Buy |
334,777
+196,096
| +141% | +$3.82M | ﹤0.01% | 2042 |
|
|
2025
Q2 | $2.79M | Buy |
138,681
+55,333
| +66% | +$1.06M | ﹤0.01% | 2590 |
|
|
2025
Q1 | $1.51M | Sell |
83,348
-27,131
| -25% | -$486K | ﹤0.01% | 2845 |
|
|
2024
Q4 | $1.92M | Buy |
110,479
+9,885
| +10% | +$190K | ﹤0.01% | 2917 |
|
|
2024
Q3 | $1.94M | Buy |
100,594
+72,192
| +254% | +$1.33M | ﹤0.01% | 2870 |
|
|
2024
Q2 | $466K | Sell |
28,402
-31,360
| -52% | -$487K | ﹤0.01% | 3080 |
|
|
2024
Q1 | $911K | Sell |
59,762
-44,906
| -43% | -$705K | ﹤0.01% | 3191 |
|
|
2023
Q4 | $1.68M | Buy |
104,668
+63,711
| +156% | +$891K | ﹤0.01% | 3056 |
|
|
2023
Q3 | $532K | Buy |
40,957
+5,995
| +17% | +$77.8K | ﹤0.01% | 2767 |
|
|
2023
Q2 | $445K | Sell |
34,962
-25,802
| -42% | -$323K | ﹤0.01% | 2829 |
|
|
2023
Q1 | $684K | Buy |
60,764
+753
| +1% | +$9.14K | ﹤0.01% | 3029 |
|
|
2022
Q4 | $795K | Sell |
60,011
-7,053
| -11% | -$92.7K | ﹤0.01% | 2984 |
|
|
2022
Q3 | $779K | Sell |
67,064
-25,003
| -27% | -$343K | ﹤0.01% | 2398 |
|
|
2022
Q2 | $1.36M | Buy |
92,067
+14,592
| +19% | +$239K | ﹤0.01% | 2124 |
|
|
2022
Q1 | $1.5M | Sell |
77,475
-8,338
| -10% | -$149K | ﹤0.01% | 2092 |
|
|
2021
Q4 | $1.48M | Buy |
85,813
+13,446
| +19% | +$229K | ﹤0.01% | 2568 |
|
|
2021
Q3 | $1.21M | Buy |
72,367
+18,923
| +35% | +$283K | ﹤0.01% | 2662 |
|
|
2021
Q2 | $717K | Sell |
53,444
-47,782
| -47% | -$598K | ﹤0.01% | 2872 |
|
|
2021
Q1 | $1.21M | Sell |
101,226
-21,632
| -18% | -$262K | ﹤0.01% | 2662 |
|
|
2020
Q4 | $1.52M | Sell |
122,858
-2,206
| -2% | -$23.8K | ﹤0.01% | 2459 |
|
|
2020
Q3 | $1.31M | Buy |
125,064
+18,379
| +17% | +$234K | ﹤0.01% | 2458 |
|
|
2020
Q2 | $1.49M | Buy |
106,685
+41,558
| +64% | +$565K | ﹤0.01% | 2392 |
|
|
2020
Q1 | $767K | Sell |
65,127
-34,406
| -35% | -$455K | ﹤0.01% | 3226 |
|
|
2019
Q4 | $1.41M | Sell |
99,533
-82,953
| -45% | -$1.02M | ﹤0.01% | 3348 |
|
|
2019
Q3 | $1.92M | Buy |
182,486
+70,561
| +63% | +$844K | ﹤0.01% | 2914 |
|
|
2019
Q2 | $1.63M | Buy |
111,925
+6,680
| +6% | +$94.7K | ﹤0.01% | 3158 |
|
|
2019
Q1 | $1.48M | Buy |
105,245
+34,283
| +48% | +$555K | ﹤0.01% | 2944 |
|
|
2018
Q4 | $1.24M | Sell |
70,962
-22,905
| -24% | -$372K | ﹤0.01% | 2901 |
|
|
2018
Q3 | $1.43M | Buy |
93,867
+28,141
| +43% | +$405K | ﹤0.01% | 3275 |
|
|
2018
Q2 | $907K | Buy |
65,726
+36,013
| +121% | +$540K | ﹤0.01% | 3389 |
|
|
2018
Q1 | $496K | Buy |
29,713
+12,359
| +71% | +$191K | ﹤0.01% | 3995 |
|
|
2017
Q4 | $246K | Sell |
17,354
-16,541
| -49% | -$221K | ﹤0.01% | 4510 |
|
|
2017
Q3 | $479K | Buy |
33,895
+14,550
| +75% | +$192K | ﹤0.01% | 3672 |
|
|
2017
Q2 | $248K | Sell |
19,345
-32,396
| -63% | -$406K | ﹤0.01% | 4183 |
|
|
2017
Q1 | $715K | Buy |
51,741
+41,373
| +399% | +$487K | ﹤0.01% | 3051 |
|
|
2016
Q4 | $111K | Buy |
10,368
+5,516
| +114% | +$57.9K | ﹤0.01% | 4670 |
|
|
2016
Q3 | $54K | Sell |
4,852
-17,428
| -78% | -$203K | ﹤0.01% | 4924 |
|
|
2016
Q2 | $235K | Buy |
22,280
+18,414
| +476% | +$218K | ﹤0.01% | 3804 |
|
|
2016
Q1 | $46K | Sell |
3,866
-505
| -12% | -$5.54K | ﹤0.01% | 4821 |
|
|
2015
Q4 | $44K | Sell |
4,371
-29,348
| -87% | -$270K | ﹤0.01% | 4873 |
|
|
2015
Q3 | $236K | Buy |
33,719
+27,871
| +477% | +$379K | ﹤0.01% | 4019 |
|
|
2015
Q2 | $105K | Sell |
5,848
-53,801
| -90% | -$924K | ﹤0.01% | 4636 |
|
|
2015
Q1 | $894K | Buy |
59,649
+46,054
| +339% | +$697K | ﹤0.01% | 3092 |
|
|
2014
Q4 | $190K | Sell |
13,595
-3,622
| -21% | -$54.4K | ﹤0.01% | 4683 |
|
|
2014
Q3 | $293K | Sell |
17,217
-12,729
| -43% | -$292K | ﹤0.01% | 4415 |
|
|
2014
Q2 | $868K | Sell |
29,946
-41,117
| -58% | -$986K | ﹤0.01% | 3463 |
|
|
2014
Q1 | $1.72M | Buy |
71,063
+63,276
| +813% | +$1.85M | ﹤0.01% | 2695 |
|
|
2013
Q4 | $220K | Sell |
7,787
-8,389
| -52% | -$245K | ﹤0.01% | 4914 |
|
|
2013
Q3 | $521K | Sell |
16,176
-49,434
| -75% | -$1.54M | ﹤0.01% | 4065 |
|
|
2013
Q2 | $2.04M | Buy |
+65,610
| New | +$1.76M | ﹤0.01% | 2524 |
|
Other funds holding INVA
VPM
VCM
SCM
SFM
Barclays's INVA Position: Q1 2026 in Review
Barclays reduced its Innoviva (INVA) stake by 27% in Q1 2026, selling an estimated $3.4M and leaving 430,879 shares worth $10M. The position accounts for ﹤0.01% of the portfolio, ranked #1450.
Barclays first reported a position in INVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.8M in Q4 2025. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.
- Barclays held 430,879 shares of Innoviva worth $10M as of Q1 2026.
- Barclays sold 157,650 Innoviva shares in Q1 2026, an estimated $3.4M.
- Innoviva made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1450 holding.
- Barclays first reported a position in Innoviva in Q2 2013 and has held it in 52 quarters since.
- Barclays's Innoviva position peaked at $11.8M in Q4 2025.
- 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.